Arnold Chiu's Research at UCLA: Unveiling Mechanisms in Gene Expression, Viral Oncology, and Cardiovascular Health

Arnold Chiu, affiliated with the University of California, Los Angeles (UCLA), has made substantial contributions to the fields of gene expression, cell cycle control, cell biology, viral oncology, and cardiovascular health. His work encompasses a wide range of topics, from the intricate mechanisms of transcription to the development of novel therapeutic strategies for heart disease. This article aims to provide an overview of Chiu's research, drawing upon a variety of publications and studies.

Gene Expression and Transcription Control

Unraveling the Mediator Complex

Chiu's research has significantly contributed to our understanding of the Mediator complex, a crucial component in gene transcription. The Mediator complex acts as a bridge between transcriptional regulators and RNA polymerase II, the enzyme responsible for synthesizing messenger RNA (mRNA).

Mediator's Role in Transcription Initiation: Chiu's work has demonstrated the Mediator's requirement for both recruitment and post-recruitment steps in transcription initiation. This suggests that the Mediator complex not only helps recruit transcription factors to the promoter region of a gene but also plays a role in the subsequent steps required to initiate mRNA synthesis.
E1A and Mediator Interaction: Studies have revealed the in vivo association of the adenovirus large E1A protein with the human Mediator complex in adenovirus-infected and -transformed cells. This interaction highlights the importance of the Mediator complex in viral gene expression and oncogenesis.
Sur2 Mediator Subunit: Chiu's research has shown that transcription control by E1A and the MAP kinase pathway occurs via the Sur2 mediator subunit. This finding provides insights into how different signaling pathways converge on the Mediator complex to regulate gene expression.
Activation Domain-Mediator Interactions: Chiu's studies have also demonstrated that activation domain-Mediator interactions promote transcription preinitiation complex assembly on promoter DNA. This suggests that activators, proteins that stimulate transcription, interact with the Mediator complex to facilitate the formation of the preinitiation complex, a necessary step for initiating transcription.

TATA-Binding Protein (TBP) and Associated Factors

The TATA-binding protein (TBP) is a crucial component of the TFIID complex, which initiates transcription by binding to the TATA box, a DNA sequence found in the promoter region of many genes. Chiu's work has shed light on the structure and function of TBP and its associated factors (TAFs).

TBP-TAF Interactions: Chiu's research has provided evidence that TAF-TATA box-binding protein interactions are required for activated transcription in mammalian cells.
TBP Surfaces Required for Activated Transcription: Studies have identified TATA-box binding protein surfaces required for activated transcription in vivo through radical mutations.
How Proteins Recognize the TATA Box: Chiu's work has explored how proteins recognize the TATA box, providing insights into the molecular mechanisms of transcription initiation.
TBP-like Factors: Chiu's research has also focused on TBP-like factors, exploring their role in transcription.
Polymerase III TBP-associated Factor Brf: Chiu's studies have shown that the Polymerase (Pol) III TATA box-binding protein (TBP)-associated factor Brf binds to a surface on TBP also required for activated Pol II transcription.

Other Key Findings in Transcription

DA-Complex Assembly Activity: Chiu's research has identified DA-complex assembly activity required for VP16C transcriptional activation.
TFIIA and TFIID Interaction: Chiu's work has shown that a class of activation domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter complex assembly.
TAFs in Transcriptional Activation: Chiu's research has proposed a mechanism for TAFs in transcriptional activation: activation domain enhancement of TFIID-TFIIA-promoter DNA complex formation.
Holo-TFIID: Chiu's studies have demonstrated that Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter.

Viral Oncology

Adenovirus and Host Cell Interactions

Adenoviruses are a group of viruses known to cause a variety of illnesses, including respiratory infections, conjunctivitis, and gastroenteritis. Chiu's research has focused on how adenoviruses interact with host cells to promote viral replication and, in some cases, oncogenesis (cancer development).

E1A's Role in Repressing Host Genes: Chiu's work has demonstrated that the adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection. This suggests that E1A manipulates the host cell's gene expression machinery to create an environment conducive to viral replication.
E1B 55-Kilodalton Protein: Chiu's research has shown that the adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies. This finding highlights the ability of adenovirus to inactivate p53, a tumor suppressor protein that plays a crucial role in preventing cancer development.
E1A Alters Histone Modification: Chiu's studies have shown that adenovirus small e1a alters global patterns of histone modification.
E1A and Epigenetic Reprogramming: Chiu's research has demonstrated epigenetic reprogramming by adenovirus e1a.
E1A Interaction with Mammalian Srb/Mediator Complex: Chiu's work has shown that the mammalian Srb/Mediator complex is targeted by adenovirus E1A protein.
E1B Protein and p53 Transactivation: Chiu's research has demonstrated that inhibition of p53 transactivation is required for transformation by adenovirus early 1B protein.
Viral Manipulation of Host Epigenome: Chiu's work has explored viral manipulation of the host epigenome for oncogenic transformation.
Aggresome Response: Chiu's studies have shown that adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex.
Viral Late mRNA Nuclear Export: Chiu's research has demonstrated that adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export.

Viral Vectors and Gene Therapy

In addition to studying the mechanisms of viral oncogenesis, Chiu's research has also explored the use of adenoviruses as vectors for gene therapy, a promising approach for treating a variety of diseases by delivering therapeutic genes to cells.

Helper-Dependent Adenovirus Vectors: Chiu's work has developed a rapid Q-PCR titration protocol for adenovirus and helper-dependent adenovirus vectors that produces biologically relevant results. This protocol is essential for accurately quantifying the amount of virus in a preparation, which is crucial for gene therapy applications.
EBV Episome Delivery: Chiu's research has shown the delivery of an EBV episome by a self-circularizing helper-dependent adenovirus, resulting in long-term transgene expression in immunocompetent mice. This finding suggests that helper-dependent adenoviruses can be used to deliver genes that are stably maintained in cells, leading to long-term therapeutic effects.

Cardiovascular Health

Recent publications involving Arnold Chiu (possibly in a collaborative role or mentorship capacity) highlight research in cardiovascular health, covering a range of topics from genetic risk scores to therapeutic interventions.

Polygenic Risk Scores and Cardiovascular Disease

Coronary Heart Disease: Evaluating Performance and Agreement of Coronary Heart Disease Polygenic Risk Scores.
Venous Thromboembolism: Multi-ancestry polygenic risk scores for venous thromboembolism.
Reducing Disparities in Polygenic Risk Assessment: The PRIMED Consortium: Reducing disparities in polygenic risk assessment.
Depression Treatment Response: Exploring depression treatment response by using polygenic risk scoring across diverse populations.

Cardiac Imaging and Interventions

Cardiac Positron Emission Tomography: Incidence of positive genetic testing among patients referred for cardiac positron emission tomography.
Quantitative Flow Ratio Uncertainty-Zone: The Quantitative Flow Ratio Uncertainty-Zone: Finding Certainty Within Uncertainty.
Shockwave Intravascular Lithotripsy: Use of Shockwave Intravascular Lithotripsy to Facilitate Transcarotid Access for Transcatheter Aortic Valve Replacement.
Intravascular Ultrasound Use: The Impact of Intravascular Ultrasound Use on 1-Year Outcomes After Infrapopliteal Endovascular Intervention.
Renal Artery Stenosis: Therapy for Renal Artery Stenosis: A Call for Change.
Artificial Intelligence-Driven Cardiovascular Computed Tomography: Enhancing coronary artery plaque analysis via artificial intelligence-driven cardiovascular computed tomography.
Point-of-Care Ultrasound Curriculum: Developing a Longitudinal Point-of-Care Ultrasound (POCUS) Curriculum for Internal Medicine Residents.
Direct-to-Catheter Ablation: Direct-to-catheter ablation versus second line catheter ablation for persistent atrial fibrillation: Effect on arrhythmia recurrence, AF burden, early left atrium remodeling and quality of life.
Lesion Delivery and Scar Formation: Lesion delivery and scar formation in catheter ablation for atrial fibrillation: The DECAAF II trial.
Left Atrial Fibrosis: History of stroke as a predictor of high left atrial fibrosis in patients with persistent atrial fibrillation-insight from the DECAAF II randomized trial.
Sex-Specific Outcomes: Sex-specific outcomes and left atrial remodeling following catheter ablation of persistent atrial fibrillation: results from the DECAAF II trial.

Heart Failure and Related Conditions

SGLT2 Inhibitors in Heart Failure: Sodium-Glucose Cotransporter 2 Inhibitors and Mycotic Genital or Urinary Tract Infections in Heart Failure.
Angiotensinogen, Sex Hormones, and Hormone Therapy: Circulating Levels of Angiotensinogen, Sex Hormones, and Hormone Therapy-The Multi-Ethnic Study of Atherosclerosis (MESA).
Kaposi Sarcoma Post-Heart Transplantation: A Case of Cutaneous Kaposi Sarcoma in a Patient Post-Heart Transplantation.
Long COVID Syndrome: Multidisciplinary Center Care for Long COVID Syndrome-A Retrospective Cohort Study.
Sudden Cardiac Death: Sudden Cardiac Death: Insights From Transcriptomics.
Polymorphic Ventricular Tachycardia: Clinical and Electrophysiological Characteristics of Inducible Polymorphic Ventricular Tachycardia in Repaired Tetralogy of Fallot.
Bioprosthetic Valve Surgery: Rethinking early anticoagulation in bioprosthetic valve surgery.
Intracardiac Echo in Congenital Heart Disease: The Growing Role of Intracardiac Echo in Congenital Heart Disease Interventions.
Percutaneous Treatment of Alterra Prestent Migration: Percutaneous Treatment of Proximal Migration of an Alterra Prestent.
Left Atrial Strain in COVID-19 Patients: Left Atrial Strain in Omicron-Type COVID-19 Patients.
Transesophageal Echocardiography in Adult Congenital Heart Disease: Highlights of Transesophageal Echocardiography During Interventions for Adult Congenital Heart Disease.
Exercise Limitation in Hypertrophic Cardiomyopathy: Exercise limitation in hypertrophic cardiomyopathy: combined stress echocardiography and cardiopulmonary exercise test.
Failing Fontan: Contemporary Management of the Failing Fontan.

Disparities and Outcomes in Cardiovascular Interventions

Racial/Ethnic Disparities: Racial/Ethnic Disparities in Outcomes After Percutaneous Coronary Intervention.
Troponin Changes and Kidney Function: Proportional troponin changes and risk for outcomes with intervention strategies in non-ST-elevation acute coronary syndrome across kidney function.